Biotech pullback and RNN’s prospects

by westcoaster | March 26, 2014 2:54 pm

I’m still holding my position in RNN despite the drop over the past week. I know there are quite a few Irregulars who own this stock, and I’d be grateful for any thoughts on where they think RNN is heading. Nothing fundamental has changed at the company; I think it’s just getting clobbered by the general biotech carnage.

Source URL: https://www.stockgumshoe.com/2014/03/microblog-biotech-pullback-and-rnns-prospects/


  1. Stephen Jackson
    Mar 27 2014, 12:44:17 am

    Paul: I believe that you are absolutely correct in your comments. This seems like a buying opportunity to me. I may add shares to my existing position.

  2. Paul Baran
    Mar 27 2014, 10:14:57 am

    Thanks Stephen. RNN reports earnings in April, and we’ll have to wait until then, I think, for any real news. I’d add more too, but I’m overweight in it already.

  3. ROBERT ROARK
    May 13 2014, 04:34:59 pm

    Won Jun Choi et. al. Fluorocyclopentenyl-cytosine with Broad Spectrum and Potent Antitumor Activity. Journal of Medicinal Chemistry. 2012 (55): 4521-4525

    THIS IS A LINK THAT WILL REASSURE EARLY INVESTORS….
    but the race is on and it looks as if “The Market” will crash before the clinical studies are completed.
    So our dilemma is whether or not to buy or sell now…or wait…

What These Icons Mean